(Q44881633)

7 December 2017

title

Population pharmacokinetic analysis of glimepiride with CYP2C9 genetic polymorphism in healthy Korean subjects (English)

1 reference

7 December 2017

1 reference

Hee-Doo Yoo

1

1 reference

7 December 2017

Mi-Suk Kim

series ordinal

2

1 reference

7 December 2017

Hea-Young Cho

series ordinal

3

1 reference

7 December 2017

Yong-Bok Lee

series ordinal

4

1 reference

7 December 2017

publication date

8 April 2011

1 reference

European Journal of Clinical Pharmacology

7 December 2017

published in

1 reference

7 December 2017

volume

67

1 reference

7 December 2017

issue

9

1 reference

7 December 2017

page(s)

889-898

1 reference

Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Absolute bioavailability of glimepiride (Amaryl) after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Predicting drug disposition via application of a Biopharmaceutics Drug Disposition Classification System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Dose linearity assessment of glimepiride (Amaryl) tablets in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Glimepiride. A review of its use in the management of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Glyburide and glimepiride pharmacokinetics in subjects with different CYP2C9 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Effect of CYP2C9 genetic polymorphisms on the efficacy and pharmacokinetics of glimepiride in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Pharmacogenetics of the major polymorphic metabolizing enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Lower frequency of CYP2C9*2 in Mexican-Americans compared to Spaniards.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

CYP2C9 allelic variants: ethnic distribution and functional significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

A double Weibull input function describes the complex absorption of sustained-release oral sodium valproate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Population pharmacokinetic modeling of oral cyclosporin using NONMEM: comparison of absorption pharmacokinetic models and design of a Bayesian estimator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Pharmacokinetic and pharmacodynamic modelling of the effects of glimepiride on insulin secretion and glucose lowering in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

A novel extravascular input function for the assessment of drug absorption in bioavailability studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Frequency of cytochrome P450 2C9 mutant alleles in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Allele and genotype frequencies of CYP2C9 in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Pharmacokinetics of glimepiride and cytochrome P450 2C9 genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1035-2

Pharmacokinetics and pharmacodynamics of glimepiride in type 2 diabetic patients: compared effects of once- versus twice-daily dosing

21 January 2018

1 reference

12 December 2020

Pharmacokinetics/genotype associations for major cytochrome P450 enzymes in native and first- and third-generation Japanese populations: comparison with Korean, Chinese, and Caucasian populations

1 reference

12 December 2020

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

12 December 2020

A simple method for the detection of CYP2C9 polymorphisms: nested allele-specific multiplex polymerase chain reaction

1 reference

12 December 2020

Simultaneous determination of the sulphonylurea glimepiride and its metabolites in human serum and urine by high-performance liquid chromatography after pre-column derivatization

1 reference

12 December 2020

Sex difference in pharmacokinetics of the novel sulfonylurea antidiabetic glimepiride in rats

1 reference

12 December 2020

10.1007/S00228-011-1035-2

Identifiers

DOI

1 reference

7 December 2017

1 reference